Cargando…
TZT‐1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death
TZT‐1027, a dolastatin 10 derivative, is an antimicrotubule agent with potent antitumor activity both in vitro and in vivo. In this study, we performed biochemical and histopathological examinations, and evaluated TZT‐1027‐induced tumoral vascular collapse and tumor cell death in an advanced tumor m...
Autores principales: | Otani, Masashi, Natsume, Tsugitaka, Watanabe, Jun‐ichi, Kobayashi, Motohiro, Murakoshi, Masanori, Mikami, Takashi, Nakayama, Takaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926421/ https://www.ncbi.nlm.nih.gov/pubmed/10965026 http://dx.doi.org/10.1111/j.1349-7006.2000.tb01022.x |
Ejemplares similares
-
Characterization of the Interaction of TZT‐1027, a Potent Antitumor Agent, with Tubulin
por: Natsume, Tsugitaka, et al.
Publicado: (2000) -
Antitumor Activity of TZT‐1027, a Novel Doiastatin 10 Derivative
por: Kobayashi, Motohiro, et al.
Publicado: (1997) -
Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents
por: Yan, Qi, et al.
Publicado: (2016) -
The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
por: Akashi, Y, et al.
Publicado: (2007) -
Quick and Simple Detection Technique to Assess the Binding of Antimicrotubule Agents to the Colchicine-Binding Site
por: Fortin, Sébastien, et al.
Publicado: (2010)